简
繁
EN
简
繁
EN
HOME
·
Telix Pharmaceuticals
Telix Pharmaceuticals: FDA Accepts Pixclara® NDA, PDUFA Goal Date Set for September 11, 2026
Tags:
Telix Pharmaceuticals
NDA
2026-04-10
Featured News
ETF
iShares Hang Seng TECH ETF (03067.HK) Rose 1.86%, with the Latest Price at HKD 10.410
ETF
CSOP Yinhua CSI 5G Communications Theme ETF (03193.HK) Rises 4.87% to HK$20.460
Finance
Frasers Property: Proposes to dispose of stakes in four logistics properties in Germany and the Netherlands for approximately 214.9 million euros
ETF
Fubon NYSE FactSet Taiwan Core Semiconductor Index ETF (03076.HK) Rises 3.62% to HK$19.480
ETF
Hang Seng TECH Index ETF (03032.HK) Rose 2.15%, with the Latest Price at HKD 4.950
ETF
Hang Seng China Enterprises Index ETF (02828.HK) Rises 0.82% to HK$88.400
ETF
Maxwealth CNI Commercial Satellite Communication Industry ETF(159206) falls 3.72%, with the latest scale reaching 22.474 billion yuan
ETF
ChinaAMC CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF(159562) rises 3.16%, aiming for a third consecutive gain
ETF
iShares FTSE China 50 Index ETF (02801.HK) Rose 0.40%, with the Latest Price at HKD 24.920
ETF
CSOP Hang Seng Tech Index ETF (03033.HK) Rises 2.48% to HK$4.874
Scan QR Code
Download App